BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Aug 27, 2026; 18(8): 118864
Published online Aug 27, 2026. doi: 10.4240/wjgs.118864
Table 1 Comparison of general data between two groups, n (%)/mean ± SD
Item
Study group (n = 59)
Control group (n = 61)
Statistic
P value
Genderχ2 = 0.4170.519
Male41 (69.5)38 (62.3)
Female18 (30.5)23 (37.7)
Age (years)56.8 ± 12.557.9 ± 13.2t = 0.4760.635
BMI (kg/m2)23.8 ± 2.624.1 ± 2.4t = 0.6640.508
Lesion locationχ2 = 2.1450.829
Rectum18 (30.5)21 (34.4)
Sigmoid colon15 (25.4)16 (26.2)
Descending colon8 (13.6)7 (11.5)
Transverse colon10 (16.9)9 (14.8)
Ascending colon6 (10.2)5 (8.2)
Cecum2 (3.4)3 (4.9)
Lesion size (cm)2.0 ± 1.11.9 ± 1.0t = 0.5230.602
Surgical methodχ2 = 3.2540.071
EMR43 (72.9)55 (90.2)
ESD16 (27.1)6 (9.8)
Comorbid underlying diseases
Hypertension21 (35.6)24 (39.3)χ2 = 0.1740.677
Diabetes11 (18.6)13 (21.3)χ2 = 0.1270.721
Coronary heart disease5 (8.5)7 (11.5)χ2 = 0.2850.593
Preoperative hemoglobin (g/L)136.4 ± 15.3138.1 ± 14.8t = 0.6240.534
Preoperative platelet count (× 109/L)218.5 ± 52.3223.6 ± 49.7t = 0.5510.583
Prothrombin time (second)11.8 ± 1.211.6 ± 1.1t = 0.9590.339
Activated partial thromboplastin time (second)28.3 ± 3.628.7 ± 3.4t = 0.6270.532


Write to the Help Desk